Dec 21, 2024 9:55 PM
BACK TO TOP
KSE100
109,513.14
3238.17
(3.05%)
ALLSHR
69,212.12
1727.86
(2.56%)
KSE30
34,513.39
1160.10
(3.48%)
KMI30
169,490.37
5959.15
(3.64%)
BKTI
23,721.66
751.62
(3.27%)
OGTI
29,513.18
842.03
(2.94%)
KMIALLSHR
48,342.31
1335.38
(2.84%)
PSXDIV20
41,786.73
1205.74
(2.97%)
UPP9
31,892.07
1097.34
(3.56%)
NITPGI
26,577.91
851.27
(3.31%)
NBPPGI
29,098.35
814.44
(2.88%)
MZNPI
22,447.28
730.80
(3.37%)
JSMFI
36,072.05
1001.96
(2.86%)
ACI
17,436.36
512.13
(3.03%)
JSGBKTI
26,919.59
900.50
(3.46%)
MII30
15,576.22
559.74
(3.73%)
HBLTTI
15,183.43
01-11-2024
8.25
(0.05%)
Shifa International Hospitals Limited
MISCELLANEOUS
Rs.373.16
6.41
(1.75%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Fri, Dec 20, 2024 4:45 PM
REG
FUT
ODL
Open
390.00
High
390.00
Low
360.00
Volume
70,782
CIRCUIT BREAKER
330.08 — 403.43
DAY RANGE
360.00 — 390.00
52-WEEK RANGE
123.00 — 442.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
366.75
VAR
22.50
HAIRCUT
27.50
P/E Ratio (TTM) **
14.77
1-Year Change *
173.76%
YTD Change *
166.03%

No record found

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

Shifa International Hospitals Limited was incorporated in Pakistan on September 29, 1987 as a private limited company under the repealed Companies Ordinance, 1984 and converted into a public limited company on October 12, 1989. The principal activity of the Company is to establish and run medical centers and hospitals in Pakistan. The Company is also running medical centers, pharmacies and Lab collection points in different cities of Pakistan.

KEY PEOPLE
Dr. Zeeshan Bin IshtiaqueCEO
Dr. Habib ur RahmanChairperson
Muhammad NaeemCompany Secretary
ADDRESS

Sector H-8/4, Islamabad, Pakistan

WEBSITE

www.shifa.com.pk

REGISTRAR

M/s Corplink (Private) Limited, Wings Arcade, 1-K, Commercial, Model Town, Lahore

AUDITOR

BDO Ebrahim & Co. Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
23,589,079.16
Shares
63,214,383
Free Float
28,446,472
Free Float
45.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Oct 30, 2024Transmission of Quarterly Report for the Period Ended 2024-09-30 View   PDF
Oct 28, 2024Financial Results for the 1st Quarter Ended September 30, 2024 View   PDF
Oct 7, 2024Transmission of Annual Report for the Year Ended 2024-06-30 View   PDF
Sep 16, 2024Financial Results for the Year Ended 2024-06-30 View   PDF
Apr 30, 2024 Transmission of Quarterly Report for the Period Ended March 31, 2024 View   PDF
Apr 26, 2024Financial Results for the 3rd Quarter Ended 2024-03-31 View   PDF
Mar 1, 2024Transmission of Quarterly Report for the Period Ended 2023-12-31 View   PDF
Feb 29, 2024Transmission of Quarterly Report for the Period Ended 2023-12-31
REVOKED
View   PDF
Feb 26, 2024Financial Results for the 2nd Quarter (Half Year) Ended December 31, 2023 View   PDF
Oct 30, 2023Transmission of Quarterly Report for the Period Ended 2023-09-30 View   PDF
DateTitleDocument
Oct 28, 2024CERTIFIED COPY RESOLUTIONS PASSED BY THE SHAREHOLDERS IN THE 38TH ANNUAL GENERAL MEETING OF SHIFA INTERNATIONAL HOSPITALS LIMITED HELD ON OCTOBER 28, 2024 View   PDF
Oct 18, 2024Board Meeting View   PDF
Oct 7, 2024Notice of 38th Annual General Meeting 2024 View   PDF
Sep 4, 2024Board Meeting View   PDF
Jun 24, 2024Board Meeting other than Financial Results View   PDF
Jun 20, 2024Certified Copy of Resollution Adopted in Extraordinary General Meeting of Shifa International Hospitals Ltd held on June 15, 2024 View   PDF
Jun 14, 2024Board Meeting Other Than Financial Results View   PDF
May 27, 2024Notice of Extraordinary General Meeting - Newspaper Clippings View   PDF
May 24, 2024Notice of Extraordinary General Meeting View   PDF
Apr 17, 2024Board Meeting View   PDF
DateTitleDocument
Dec 20, 2024Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Dec 16, 2024Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Dec 11, 2024Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Dec 3, 2024Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Nov 28, 2024Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Nov 25, 2024Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Nov 22, 2024Corporate Briefing Session 2023-24 View   PDF
Nov 22, 2024Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Nov 20, 2024Corporate Briefing Session 2024 View   PDF
Nov 8, 2024Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Nov 6, 2024Credit of Final Cash Dividend (D-26) through Electronic Mode View   PDF
Nov 5, 2024Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Nov 5, 2024Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2024202320222021
Sales23,563,84019,721,42516,197,55114,219,718
Profit after Taxation1,362,0741,181,4061,162,549699,924
Q1 2025Q3 2024Q2 2024Q1 2024
Sales7,061,3685,783,3206,078,4005,941,386
Profit after Taxation628,675321,738351,100393,542
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2024202320222021
Gross Profit Margin (%)100.00100.00100.00100.00
Net Profit Margin (%)5.785.997.184.92
EPS Growth (%)15.301.6366.1235.33
PEG0.444.020.150.56

Payouts

DateFinancial ResultsDetailsBook Closure
September 16, 2024 3:51 PM30/06/2024(YR) 25%(F) (D) 19/10/2024 - 28/10/2024
April 26, 2024 3:29 PM31/03/2024(IIIQ) 15%(i) (D) 10/05/2024 - 12/05/2024
October 2, 2023 3:18 PM30/06/2023(YR) 15%(F) (D) 20/10/2023 - 27/10/2023
September 29, 2022 11:28 AM30/06/2022(YR) 15%(F) (D) 21/10/2022 - 28/10/2022
April 28, 2022 12:49 PM31/03/2022(IIIQ) 15% (D) 12/05/2022 - 14/05/2022
September 27, 2021 12:37 PM30/06/2021(YR) 2% (B) 21/10/2021 - 28/10/2021
September 16, 2019 2:13 PM30/06/2019(YR) 25.5% (F) (D) 19/10/2019 - 26/10/2019
September 10, 2018 9:50 AM30/06/2018(YR) 45% (D) 18/10/2018 - 27/10/2018
September 12, 2017 9:54 AM30/06/2017(YR) 50% (D) 18/10/2017 - 27/10/2017
August 25, 2016 3:21 PM30/06/2016(YR) 30% (D) 22/10/2016 - 29/10/2016

Financial Reports